Screening for Colorectal Carcinoma in India: Real-World Scenario, Pitfalls, and Solutions

Among various cancer programs, screening sigmoidoscopy has proved to improve both CRC-specific mortality and all-cause mortality. Unfortunately, its utilization is suboptimal, at best. Even among the highly educated medical community, the real-world utility was only in 7.14% of the eligible population. Barriers include invasive nature of intervention, need for appropriate bowel preparation, operator dependence, and small but significant risk of serious toxicity. An important method of increasing utility of screening colonoscopy is use of a test that can identify high-risk population, who can then be persuaded to undergo screening colonoscopy. This is the value of recently developed noninvasive blood- and stool-based tests, like Guardant Health's Shield. Being U.S. Food and Drug Administration (FDA) approved with specificity of 90% and sensitivity of 84%, it should be offered to all eligible persons who can afford it, thereby increasing colonoscopy use and potentially saving lives.

Authors

Institutions

Publication Details

Journal
South Asian Journal of Cancer
Published
2024-10-01
DOI
https://doi.org/10.1055/s-0045-1802655
Citations
4
Primary Topic
Colorectal Cancer Screening and Detection
Type
article
Field-Weighted Citation Impact
1.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Screening for Colorectal Carcinoma in India: Real-World Scenario, Pitfalls, and Solutions

Deepak Agrawal, Purvish M. Parikh, Adwaith Krishna Surendran, Mansi Agrawal et al.
4 citations
South Asian Journal of Cancer
Colorectal Cancer Screening and Detection
1.13
article

Screening for Colorectal Carcinoma in India: Real-World Scenario, Pitfalls, and Solutions

Deepak Agrawal, Purvish M. Parikh, Adwaith Krishna Surendran, Mansi Agrawal, Praveen Nandha Kumar Pitchan Velammal, Anika Goel, Ashutosh Pathak, Mallika Mittal, Karthik Kanna Venkatesh, Vignesh Babu K, Archana Sameer Vinakar, Sarvesh Zope
article en
4 citations

Abstract

Among various cancer programs, screening sigmoidoscopy has proved to improve both CRC-specific mortality and all-cause mortality. Unfortunately, its utilization is suboptimal, at best. Even among the highly educated medical community, the real-world utility was only in 7.14% of the eligible population. Barriers include invasive nature of intervention, need for appropriate bowel preparation, operator dependence, and small but significant risk of serious toxicity. An important method of increasing utility of screening colonoscopy is use of a test that can identify high-risk population, who can then be persuaded to undergo screening colonoscopy. This is the value of recently developed noninvasive blood- and stool-based tests, like Guardant Health's Shield. Being U.S. Food and Drug Administration (FDA) approved with specificity of 90% and sensitivity of 84%, it should be offered to all eligible persons who can afford it, thereby increasing colonoscopy use and potentially saving lives.

South Asian Journal of CancerVol. 13(04)
Tirunelveli Medical College (IN), Tata Institute of Fundamental Research (IN), Madras Medical College (IN), Mahatma Gandhi University (IN), Government of India (IN), Mahatma Gandhi Memorial Medical College (IN), Punjab Institute of Medical Sciences (IN), Kakatiya University (IN), Jawaharlal Nehru Medical College (IN), All India Institute of Medical Sciences Bhopal (IN), Jawaharlal Institute of Post Graduate Medical Education and Research (IN), Bangalore Medical College and Research Institute (IN)
Openalex Percentile: Top 17%
Colorectal Cancer Screening and Detection
1.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.